ACTRN12621000622808已完成未知
A observational long term Phase I/II study of the MAG200 randomised, double blind, placebo-controlled, single ascending dose study to evaluate the efficacy and longer-term safety and tolerability of allogeneic adipose-derived mesenchymal stem cells in the treatment of symptomatic knee osteoarthritis.
Magellan Biologicals Pty Ltd0 个研究点目标入组 40 人开始时间: 2021年5月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •i) Body mass index BMI must be 'greater than or equal' to 19.0 kg/m2 and 'less than or equal to' 35.0 kg/m2;
- •ii) A documented diagnosis of osteoarthritis (Grade 2 or Grade 3) of the study knee
- •iii) Participants enrolled in the interventional MAG200 study (ACTRN12617001095358)
排除标准
- •i) MRI-confirmed displaced meniscal tear, ligament deficiency or generalised Grade 4 chondral loss in the study knee.
- •ii) History of or suspected infective or inflammatory joint disorders.
- •iii) Joint surgery within 3 years prior to study start.
- •iv) Females who are pregnant or planning a pregnancy during the following 12 months.
- •v) Any contraindication to intra-articular injection.
- •vi) Any contraindication to an X-ray or MRI of the study knee.
研究者
相似试验
尚未招募
不适用
A prospective observational study of first-line systemic therapy in Thai advanced hepatocellular carcinoma patientsefficacy of first line systemic therapy in HCCHCC,first line,systemic therapy,chemotherapy,targeted therapy,PFS,OSTCTR20200921003Thai society of clinical oncology (TSCO)403
进行中（未招募）
1 期
A Clinical Research Study for People with Relapsing Multiple SclerosisRelapsing multiple sclerosisMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-002631-42-FIMerck KGaA300
进行中（未招募）
1 期
A Clinical Research Study for People with Relapsing Multiple SclerosisRelapsing multiple sclerosisMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-002631-42-HUMerck KGaA300
进行中（未招募）
1 期
A Clinical Research Study for People with Relapsing Multiple SclerosisEUCTR2017-002631-42-ATMerck KGaA265
进行中（未招募）
1 期
A Clinical Research Study for People with Relapsing Multiple SclerosisEUCTR2017-002631-42-SEMerck KGaA265